Loading clinical trials...
Loading clinical trials...
Safety and Effectiveness of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertension Patients
Conditions
Locations
17
Taiwan
Boehringer Ingelheim Investigator Site
Changhua, Taiwan
Boehringer Ingelheim Investigator Site 1
Chiayi City, Taiwan
Boehringer Ingelheim Investigator Site 2
Chiayi City, Taiwan
Boehringer Ingelheim Investigator Site
Keelung, Taiwan
Boehringer Ingelheim Investigator Site
Ksohsiung, Taiwan
Boehringer Ingelheim Investigator Site
Miaoli, Taiwan
Start Date
December 1, 2006
Primary Completion Date
December 1, 2008
Last Updated
April 7, 2014
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions